Share your contact details to receive free updated sample copy/pages of the recently published edition of Clinical Nutrition Market Report 2023.
Key Insights from Clinical Nutrition Market Report
As per Cognitive Market Research's latest published report, the Global Clinical Nutrition market size will be USD 57.27 Billion by 2030. Clinical Nutrition Industry's Compound Annual Growth Rate will be 6.50% from 2023 to 2030.
Global Clinical Nutrition Market Compound Annual Growth Rate (CAGR) for 2023 to 2030 | 6.5% |
Clinical Nutrition Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Clinical Nutrition Market Report Description
Introduction of Clinical Nutrition
Clinical nutrition is a branch of medicine deals with the prevention, diagnosis, and management of nutritional changes in patients related to the chronic diseases and conditions primarily in health care. This studies the nutrition impacts on health and well-being of individuals. Clinical nutrition incorporates primarily the scientific fields of nutrition and dietetics that aims to maintain a healthy energy balance, while also providing sufficient amounts of nutrients such as protein, vitamins, and minerals to patients.
What is Driving Clinical Nutrition Market?
Increasing prevalence of metabolic disorders coupled with high investments and spending in healthcare in developed as well as developing countries is the primary factor driving the growth of the clinical nutrition market. In addition, growing geriatric population and rising disposable income are expected to drive the clinical nutrition market. Development of clinical nutrition for different age group and awareness about health nutrients due to education and information availability provides opportunities to the global clinical nutrition market.
Base Year | 2022 |
Historical Data Time Period | 2018-2022 |
Forecast Period | 2023-2030 |
Report Edition | 7th Edition (2023) |
Last Update | Last Updated In April 2023 |
Next Report Edition | June 2023 (Pre-Booking Available) |
Market Forecast/Projection Time Period | 2023-2030 |
Report Format | PDF | PPT | Excel | Word | Bi |
Report ID | CMR652369 |
Clinical Nutrition Market Report 2023 (Global Edition) Table of Content differs according to the user License selection. Current Displayed TOC is for the Single User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report. Specific section/s of report can be ordered at a discounted price. If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Table of Content (Revenue USD Edition), (Enquire about Volume/Consumption Edition Data)
- 1.1 Global Clinical Nutrition Industry Introduction
- 1.2 Objectives of the Study
- 1.3 USP of the Report
- 1.4 Who is this report for?
- 1.5 Designing of Market Scope
- 1.5.1 Clinical Nutrition Market Segmentation
- 1.5.1 Clinical Nutrition Market Regional Fragmentation
- 1.5.1 Clinical Nutrition Market Players
- 1.6 Report Duration
- 1.7 List of Stakeholders
- 2.1 Clinical Nutrition Market Report 2023 Research Methodology
- 2.2 Systematic Research Approach
- 2.2.1 Primary Research
- 2.2.1.1 Key Data from Primary
- 2.2.1.2 Primary Interviews with Experts
- 2.2.1.3 Key Industry Insights
- 2.2.1.4 Questionnaire
At Cognitive Market Research, we have designed questionnaire focused on Clinical Nutrition Market for the statistical study. This questionnaire is the key part of our research methodology which is shared with number of Clinical Nutrition industry experts of entire value chain, located across the globe. This study help us to gather accurate quantitative and qualitative data for the final report.
- 2.2.1.5 Breakdown of Primaries
- 2.2.2 Secondary Research
- 2.2.2.1 Key Data from Secondary
- 2.2.2.2 Paid Sources
- 2.2.2.3 Public Sources
- 2.2.1 Primary Research
- 2.3 Market Size Estimation
- 2.3.1 Top-Down Approach
- 2.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 2.3.1 Bottom-UP Approach
- 2.3.1.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 2.3.1 Top-Down Approach
- 2.4 Market Breakdown and Data Triangulation
- 2.5 Research Assumptions
- 3.1 Global Clinical Nutrition Market Size 2018 – 2030, (USD Million)
- 3.2 Global Clinical Nutrition Value, Absolute & Opportunity Analysis
- 3.3 Global Clinical Nutrition Market Y-o-Y Growth Rate Projection by Region (2023 - 2030)
- 3.4 Global Clinical Nutrition Market Statistics 2022: Snapshot
- 4.1 Clinical Nutrition Introduction
- 4.2 Global Clinical Nutrition Market Statistics by Regions (2018-2030)
- 4.2.1 North America Clinical Nutrition Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.2 Europe Clinical Nutrition Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.3 Asia Pacific Clinical Nutrition Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.4 Latin America Clinical Nutrition Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.5 Middle East and Africa Clinical Nutrition Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.3 Global Clinical Nutrition Market Size (2018-2030)
- 4.3.1 Global Clinical Nutrition Revenue Status and Outlook (2018-2030)
- 4.4 Global Clinical Nutrition Market Price Analysis by Regions (2018-2030)
- 5.1 Global Clinical Nutrition Market Revenue and Share by Manufacturers (2018-2022)
- 5.2 Global Clinical Nutrition Industry Mergers and Acquisition Analysis
- 5.3 Global Clinical Nutrition New Launches Analysis
- 5.4 Company Categorization
- 5.5 Global Clinical Nutrition Top Winning Strategies, by Manufacturers (2018-2022)
- 7.1 Clinical Nutrition Industrial Dynamics
- 7.1.1 Global Clinical Nutrition Market Drivers
- 7.1.2 Global Clinical Nutrition Market Restrains
- 7.1.3 Global Clinical Nutrition Market Opportunities
- 7.1.4 Global Clinical Nutrition Market Trends
- 7.1.5 Global Clinical Nutrition Technology (Road Map)
- 7.2 Clinical Nutrition Market Attractiveness Analysis
- 7.1.1 Market Attractiveness Analysis by Type Segment
- 7.1.2 Market Attractiveness Analysis by Application Segment
- 7.3 PESTEL Analysis for Clinical Nutrition Market
- 7.3.1 Political Factors
- 7.3.2 Economic Factors
- 7.3.3 Social Factors
- 7.3.4 Technological Factors
- 7.3.5 Legal Factors
- 7.3.6 Environmental Factors
- 7.4 Porter’s Five Forces Analysis for Clinical Nutrition Market
- 7.4.1 Bargaining Power of Suppliers
- 7.4.2 Bargaining Power of Buyers
- 7.4.3 Threat of Substitutes
- 7.4.4 Threat of New Entrants
- 7.4.5 Degree of Competition
- 7.5 of Clinical Nutrition Market Product Life Cycle
- 7.6 COVID-19 Impact on Clinical Nutrition Industry
- 7.4.1 Overall Impact of COVID-19 on Clinical Nutrition Industry
- 7.4.2 Post COVID-19 Impact and Recovery Analysis
- 7.4.3 Influencing Factors
- 7.7 Consumer Preference Analysis for Clinical Nutrition Market
- 7.8 Patent Analysis of Clinical Nutrition
- 7.9 Clinical Nutrition Industrial Chain Analysis
- 7.10 Manufacturing Cost Analysis
- 7.11 Supply Side Analysis
- 8.1 Abbott Nutrition
- 8.1.1 Abbott Nutrition Company Basic Information, and Sales Area
- 8.1.2 Abbott Nutrition Business Segment/ Overview
- 8.1.3 Abbott Nutrition Financials
- 8.1.3.1 Investment in Research and Development
- 8.1.3.2 Abbott Nutrition Sales Revenue (2018-2022)
- 8.1.3.3 Abbott Nutrition Market Share (2018-2022)
- 8.1.4 Abbott Nutrition Recent Developments
- 8.1.5 Abbott Nutrition Business Strategy
- 8.1.6 Abbott Nutrition Management Change
- 8.1.7 Abbott Nutrition SWOT Analysis
- 8.1.7.1 Strength
- 8.1.7.2 Weakness
- 8.1.7.3 Opportunity
- 8.1.7.4 Threats
- 8.1.8 Abbott Nutrition COVID-19 Impact Analysis
- 8.2 B. Braun Melsungen
- 8.2.1 B. Braun Melsungen Company Basic Information, and Sales Area
- 8.2.2 B. Braun Melsungen Business Segment/ Overview
- 8.2.3 B. Braun Melsungen Financials
- 8.2.3.1 Investment in Research and Development
- 8.2.3.2 B. Braun Melsungen Sales Revenue (2018-2022)
- 8.2.3.3 B. Braun Melsungen Market Share (2018-2022)
- 8.2.4 B. Braun Melsungen Recent Developments
- 8.2.5 B. Braun Melsungen Business Strategy
- 8.2.6 B. Braun Melsungen Management Change
- 8.2.7 B. Braun Melsungen SWOT Analysis
- 8.2.7.1 Strength
- 8.2.7.2 Weakness
- 8.2.7.3 Opportunity
- 8.2.7.4 Threats
- 8.2.8 B. Braun Melsungen COVID-19 Impact Analysis
- 8.3 Baxter International
- 8.3.1 Baxter International Company Basic Information, and Sales Area
- 8.3.2 Baxter International Business Segment/ Overview
- 8.3.3 Baxter International Financials
- 8.3.3.1 Investment in Research and Development
- 8.3.3.2 Baxter International Sales Revenue (2018-2022)
- 8.3.3.3 Baxter International Market Share (2018-2022)
- 8.3.4 Baxter International Recent Developments
- 8.3.5 Baxter International Business Strategy
- 8.3.6 Baxter International Management Change
- 8.3.7 Baxter International SWOT Analysis
- 8.3.7.1 Strength
- 8.3.7.2 Weakness
- 8.3.7.3 Opportunity
- 8.3.7.4 Threats
- 8.3.8 Baxter International COVID-19 Impact Analysis
- 8.4 Claris Lifesciences
- 8.4.1 Claris Lifesciences Company Basic Information, and Sales Area
- 8.4.2 Claris Lifesciences Business Segment/ Overview
- 8.4.3 Claris Lifesciences Financials
- 8.4.3.1 Investment in Research and Development
- 8.4.3.2 Claris Lifesciences Sales Revenue (2018-2022)
- 8.4.3.3 Claris Lifesciences Market Share (2018-2022)
- 8.4.4 Claris Lifesciences Recent Developments
- 8.4.5 Claris Lifesciences Business Strategy
- 8.4.6 Claris Lifesciences Management Change
- 8.4.7 Claris Lifesciences SWOT Analysis
- 8.4.7.1 Strength
- 8.4.7.2 Weakness
- 8.4.7.3 Opportunity
- 8.4.7.4 Threats
- 8.4.8 Claris Lifesciences COVID-19 Impact Analysis
- 8.5 Claris Otsuka Private
- 8.5.1 Claris Otsuka Private Company Basic Information, and Sales Area
- 8.5.2 Claris Otsuka Private Business Segment/ Overview
- 8.5.3 Claris Otsuka Private Financials
- 8.5.3.1 Investment in Research and Development
- 8.5.3.2 Claris Otsuka Private Sales Revenue (2018-2022)
- 8.5.3.3 Claris Otsuka Private Market Share (2018-2022)
- 8.5.4 Claris Otsuka Private Recent Developments
- 8.5.5 Claris Otsuka Private Business Strategy
- 8.5.6 Claris Otsuka Private Management Change
- 8.5.7 Claris Otsuka Private SWOT Analysis
- 8.5.7.1 Strength
- 8.5.7.2 Weakness
- 8.5.7.3 Opportunity
- 8.5.7.4 Threats
- 8.5.8 Claris Otsuka Private COVID-19 Impact Analysis
- 8.6 Fresenius Kabi
- 8.6.1 Fresenius Kabi Company Basic Information, and Sales Area
- 8.6.2 Fresenius Kabi Business Segment/ Overview
- 8.6.3 Fresenius Kabi Financials
- 8.6.3.1 Investment in Research and Development
- 8.6.3.2 Fresenius Kabi Sales Revenue (2018-2022)
- 8.6.3.3 Fresenius Kabi Market Share (2018-2022)
- 8.6.4 Fresenius Kabi Recent Developments
- 8.6.5 Fresenius Kabi Business Strategy
- 8.6.6 Fresenius Kabi Management Change
- 8.6.7 Fresenius Kabi SWOT Analysis
- 8.6.7.1 Strength
- 8.6.7.2 Weakness
- 8.6.7.3 Opportunity
- 8.6.7.4 Threats
- 8.6.8 Fresenius Kabi COVID-19 Impact Analysis
- 8.7 Groupe Danone
- 8.7.1 Groupe Danone Company Basic Information, and Sales Area
- 8.7.2 Groupe Danone Business Segment/ Overview
- 8.7.3 Groupe Danone Financials
- 8.7.3.1 Investment in Research and Development
- 8.7.3.2 Groupe Danone Sales Revenue (2018-2022)
- 8.7.3.3 Groupe Danone Market Share (2018-2022)
- 8.7.4 Groupe Danone Recent Developments
- 8.7.5 Groupe Danone Business Strategy
- 8.7.6 Groupe Danone Management Change
- 8.7.7 Groupe Danone SWOT Analysis
- 8.7.7.1 Strength
- 8.7.7.2 Weakness
- 8.7.7.3 Opportunity
- 8.7.7.4 Threats
- 8.7.8 Groupe Danone COVID-19 Impact Analysis
- 8.8 Huarui Pharmaceutical
- 8.8.1 Huarui Pharmaceutical Company Basic Information, and Sales Area
- 8.8.2 Huarui Pharmaceutical Business Segment/ Overview
- 8.8.3 Huarui Pharmaceutical Financials
- 8.8.3.1 Investment in Research and Development
- 8.8.3.2 Huarui Pharmaceutical Sales Revenue (2018-2022)
- 8.8.3.3 Huarui Pharmaceutical Market Share (2018-2022)
- 8.8.4 Huarui Pharmaceutical Recent Developments
- 8.8.5 Huarui Pharmaceutical Business Strategy
- 8.8.6 Huarui Pharmaceutical Management Change
- 8.8.7 Huarui Pharmaceutical SWOT Analysis
- 8.8.7.1 Strength
- 8.8.7.2 Weakness
- 8.8.7.3 Opportunity
- 8.8.7.4 Threats
- 8.8.8 Huarui Pharmaceutical COVID-19 Impact Analysis
- 8.9 ICU Medical
- 8.9.1 ICU Medical Company Basic Information, and Sales Area
- 8.9.2 ICU Medical Business Segment/ Overview
- 8.9.3 ICU Medical Financials
- 8.9.3.1 Investment in Research and Development
- 8.9.3.2 ICU Medical Sales Revenue (2018-2022)
- 8.9.3.3 ICU Medical Market Share (2018-2022)
- 8.9.4 ICU Medical Recent Developments
- 8.9.5 ICU Medical Business Strategy
- 8.9.6 ICU Medical Management Change
- 8.9.7 ICU Medical SWOT Analysis
- 8.9.7.1 Strength
- 8.9.7.2 Weakness
- 8.9.7.3 Opportunity
- 8.9.7.4 Threats
- 8.9.8 ICU Medical COVID-19 Impact Analysis
- 8.10 Mead Johnson Nutrition
- 8.10.1 Mead Johnson Nutrition Company Basic Information, and Sales Area
- 8.10.2 Mead Johnson Nutrition Business Segment/ Overview
- 8.10.3 Mead Johnson Nutrition Financials
- 8.10.3.1 Investment in Research and Development
- 8.10.3.2 Mead Johnson Nutrition Sales Revenue (2018-2022)
- 8.10.3.3 Mead Johnson Nutrition Market Share (2018-2022)
- 8.10.4 Mead Johnson Nutrition Recent Developments
- 8.10.5 Mead Johnson Nutrition Business Strategy
- 8.10.6 Mead Johnson Nutrition Management Change
- 8.10.7 Mead Johnson Nutrition SWOT Analysis
- 8.10.7.1 Strength
- 8.10.7.2 Weakness
- 8.10.7.3 Opportunity
- 8.10.7.4 Threats
- 8.10.8 Mead Johnson Nutrition COVID-19 Impact Analysis
- 8.11 Meiji
- 8.11.1 Meiji Company Basic Information, and Sales Area
- 8.11.2 Meiji Business Segment/ Overview
- 8.11.3 Meiji Financials
- 8.11.3.1 Investment in Research and Development
- 8.11.3.2 Meiji Sales Revenue (2018-2022)
- 8.11.3.3 Meiji Market Share (2018-2022)
- 8.11.4 Meiji Recent Developments
- 8.11.5 Meiji Business Strategy
- 8.11.6 Meiji Management Change
- 8.11.7 Meiji SWOT Analysis
- 8.11.7.1 Strength
- 8.11.7.2 Weakness
- 8.11.7.3 Opportunity
- 8.11.7.4 Threats
- 8.11.8 Meiji COVID-19 Impact Analysis
- 8.12 Nestl Health Science
- 8.12.1 Nestl Health Science Company Basic Information, and Sales Area
- 8.12.2 Nestl Health Science Business Segment/ Overview
- 8.12.3 Nestl Health Science Financials
- 8.12.3.1 Investment in Research and Development
- 8.12.3.2 Nestl Health Science Sales Revenue (2018-2022)
- 8.12.3.3 Nestl Health Science Market Share (2018-2022)
- 8.12.4 Nestl Health Science Recent Developments
- 8.12.5 Nestl Health Science Business Strategy
- 8.12.6 Nestl Health Science Management Change
- 8.12.7 Nestl Health Science SWOT Analysis
- 8.12.7.1 Strength
- 8.12.7.2 Weakness
- 8.12.7.3 Opportunity
- 8.12.7.4 Threats
- 8.12.8 Nestl Health Science COVID-19 Impact Analysis
- 8.13 Nutricia North America
- 8.13.1 Nutricia North America Company Basic Information, and Sales Area
- 8.13.2 Nutricia North America Business Segment/ Overview
- 8.13.3 Nutricia North America Financials
- 8.13.3.1 Investment in Research and Development
- 8.13.3.2 Nutricia North America Sales Revenue (2018-2022)
- 8.13.3.3 Nutricia North America Market Share (2018-2022)
- 8.13.4 Nutricia North America Recent Developments
- 8.13.5 Nutricia North America Business Strategy
- 8.13.6 Nutricia North America Management Change
- 8.13.7 Nutricia North America SWOT Analysis
- 8.13.7.1 Strength
- 8.13.7.2 Weakness
- 8.13.7.3 Opportunity
- 8.13.7.4 Threats
- 8.13.8 Nutricia North America COVID-19 Impact Analysis
- 8.14 Otsuka Pharmaceutical Factory
- 8.14.1 Otsuka Pharmaceutical Factory Company Basic Information, and Sales Area
- 8.14.2 Otsuka Pharmaceutical Factory Business Segment/ Overview
- 8.14.3 Otsuka Pharmaceutical Factory Financials
- 8.14.3.1 Investment in Research and Development
- 8.14.3.2 Otsuka Pharmaceutical Factory Sales Revenue (2018-2022)
- 8.14.3.3 Otsuka Pharmaceutical Factory Market Share (2018-2022)
- 8.14.4 Otsuka Pharmaceutical Factory Recent Developments
- 8.14.5 Otsuka Pharmaceutical Factory Business Strategy
- 8.14.6 Otsuka Pharmaceutical Factory Management Change
- 8.14.7 Otsuka Pharmaceutical Factory SWOT Analysis
- 8.14.7.1 Strength
- 8.14.7.2 Weakness
- 8.14.7.3 Opportunity
- 8.14.7.4 Threats
- 8.14.8 Otsuka Pharmaceutical Factory COVID-19 Impact Analysis
- 9.1 Detailed Qualitative Analysis
- 9.2 Global Clinical Nutrition Revenue and Share (%) by Type (2018-2030)
- 9.2.1 Infant Nutrition Market Size
- 9.2.1.1 Global Infant Nutrition Market Share and Revenue (USD Million) for 2018-2030
- 9.2.1.2 Clinical Nutrition Market for Infant Nutrition, by Country (2021 Vs 2024)
- 9.2.2 Enteral Nutrition Market Size
- 9.2.2.1 Global Enteral Nutrition Market Share and Revenue (USD Million) for 2018-2030
- 9.2.2.2 Clinical Nutrition Market for Enteral Nutrition, by Country (2021 Vs 2024)
- 9.2.3 Parenteral Nutrition Market Size
- 9.2.3.1 Global Parenteral Nutrition Market Share and Revenue (USD Million) for 2018-2030
- 9.2.3.2 Clinical Nutrition Market for Parenteral Nutrition, by Country (2021 Vs 2024)
- 9.2.1 Infant Nutrition Market Size
- 10.1 Detailed Qualitative Analysis
- 10.2 Global Clinical Nutrition Revenue and Share (%) by Application (2018-2030)
- 10.2.1 Cancer Market Size
- 10.2.1.1 Global Cancer Market Share and Revenue (USD Million) for 2018-2030
- 10.2.1.2 Clinical Nutrition Market for Cancer, by Country (2021 Vs 2024)
- 10.2.2 Metabolic Disorders Market Size
- 10.2.2.1 Global Metabolic Disorders Market Share and Revenue (USD Million) for 2018-2030
- 10.2.2.2 Clinical Nutrition Market for Metabolic Disorders, by Country (2021 Vs 2024)
- 10.2.3 Gastrointestinal Disorders Market Size
- 10.2.3.1 Global Gastrointestinal Disorders Market Share and Revenue (USD Million) for 2018-2030
- 10.2.3.2 Clinical Nutrition Market for Gastrointestinal Disorders, by Country (2021 Vs 2024)
- 10.2.4 Neurological Disorders Market Size
- 10.2.4.1 Global Neurological Disorders Market Share and Revenue (USD Million) for 2018-2030
- 10.2.4.2 Clinical Nutrition Market for Neurological Disorders, by Country (2021 Vs 2024)
- 10.2.5 Others Market Size
- 10.2.5.1 Global Others Market Share and Revenue (USD Million) for 2018-2030
- 10.2.5.2 Clinical Nutrition Market for Others, by Country (2021 Vs 2024)
- 10.2.1 Cancer Market Size
- 11.1 Detailed Qualitative Analysis
- 11.2 Global Clinical Nutrition Revenue and Share (%) by End User (2018-2030)
- 11.2.1 Infant And Child Market Size
- 11.2.1.1 Global Infant And Child Market Share and Revenue (USD Million) for 2018-2030
- 11.2.1.2 Clinical Nutrition Market for Infant And Child, by Country (2021 Vs 2024)
- 11.2.2 Adults Market Size
- 11.2.2.1 Global Adults Market Share and Revenue (USD Million) for 2018-2030
- 11.2.2.2 Clinical Nutrition Market for Adults, by Country (2021 Vs 2024)
- 11.2.3 Geriatrics Market Size
- 11.2.3.1 Global Geriatrics Market Share and Revenue (USD Million) for 2018-2030
- 11.2.3.2 Clinical Nutrition Market for Geriatrics, by Country (2021 Vs 2024)
- 11.2.1 Infant And Child Market Size
- 12.1 Detailed Qualitative Analysis
- 12.2 Global Clinical Nutrition Market Revenue by Region (2018-2030)
- 12.2 Global Clinical Nutrition Market Share (%) by Region (2018-2030)
- 13.1 North America
- 13.1.1 North America Clinical Nutrition Market Trends and Analysis
- 13.1.2 North America Clinical Nutrition Market by Country, 2018-2030
- 13.1.3 North America Clinical Nutrition Market Attractiveness Analysis by Country
- 13.2 North America Clinical Nutrition Market Size (2018-2030)
- 13.2.1 North America Clinical Nutrition Market (USD Million) by Type (2018-2030)
- 13.2.1.1 Infant Nutrition
- 13.2.1.1.1 North America Infant Nutrition Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.2 Enteral Nutrition
- 13.2.1.2.1 North America Enteral Nutrition Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.3 Parenteral Nutrition
- 13.2.1.3.1 North America Parenteral Nutrition Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.1 Infant Nutrition
- 13.2.2 North America Clinical Nutrition Market (USD Million) by Application (2018-2030)
- 13.2.2.1 Cancer
- 13.2.2.1.1 North America Cancer Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.2 Metabolic Disorders
- 13.2.2.2.1 North America Metabolic Disorders Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.3 Gastrointestinal Disorders
- 13.2.2.3.1 North America Gastrointestinal Disorders Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.4 Neurological Disorders
- 13.2.2.4.1 North America Neurological Disorders Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.5 Others
- 13.2.2.5.1 North America Others Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.1 Cancer
- 13.2.3 North America Clinical Nutrition Market (USD Million) by End User (2018-2030)
- 13.2.3.1 Infant And Child
- 13.2.3.1.1 North America Infant And Child Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.2 Adults
- 13.2.3.2.1 North America Adults Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.3 Geriatrics
- 13.2.3.3.1 North America Geriatrics Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.1 Infant And Child
- 13.2.1 North America Clinical Nutrition Market (USD Million) by Type (2018-2030)
- 14.1 Europe
- 14.1.1 Europe Clinical Nutrition Market Trends and Analysis
- 14.1.2 Europe Clinical Nutrition Market by Country, 2018-2030
- 14.1.3 Europe Clinical Nutrition Market Attractiveness Analysis by Country
- 14.2 Europe Clinical Nutrition Market Size (2018-2030)
- 14.2.1 Europe Clinical Nutrition Market (USD Million) by Type (2018-2030)
- 14.2.1.1 Infant Nutrition
- 14.2.1.1.1 Europe Infant Nutrition Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.2 Enteral Nutrition
- 14.2.1.2.1 Europe Enteral Nutrition Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.3 Parenteral Nutrition
- 14.2.1.3.1 Europe Parenteral Nutrition Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.1 Infant Nutrition
- 14.2.2 Europe Clinical Nutrition Market (USD Million) by Application (2018-2030)
- 14.2.2.1 Cancer
- 14.2.2.1.1 Europe Cancer Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.2 Metabolic Disorders
- 14.2.2.2.1 Europe Metabolic Disorders Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.3 Gastrointestinal Disorders
- 14.2.2.3.1 Europe Gastrointestinal Disorders Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.4 Neurological Disorders
- 14.2.2.4.1 Europe Neurological Disorders Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.5 Others
- 14.2.2.5.1 Europe Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.1 Cancer
- 14.2.3 Europe Clinical Nutrition Market (USD Million) by End User (2018-2030)
- 14.2.3.1 Infant And Child
- 14.2.3.1.1 Europe Infant And Child Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.2 Adults
- 14.2.3.2.1 Europe Adults Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.3 Geriatrics
- 14.2.3.3.1 Europe Geriatrics Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.1 Infant And Child
- 14.2.1 Europe Clinical Nutrition Market (USD Million) by Type (2018-2030)
- 15.1 Asia Pacific
- 15.1.1 Asia Pacific Clinical Nutrition Market Trends and Analysis
- 15.1.2 Asia Pacific Clinical Nutrition Market by Country, 2018-2030
- 15.1.3 Asia Pacific Clinical Nutrition Market Attractiveness Analysis by Country
- 15.2 Asia Pacific Clinical Nutrition Market Size (2018-2030)
- 15.2.1 Asia Pacific Clinical Nutrition Market (USD Million) by Type (2018-2030)
- 15.2.1.1 Infant Nutrition
- 15.2.1.1.1 Asia Pacific Infant Nutrition Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.2 Enteral Nutrition
- 15.2.1.2.1 Asia Pacific Enteral Nutrition Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.3 Parenteral Nutrition
- 15.2.1.3.1 Asia Pacific Parenteral Nutrition Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.1 Infant Nutrition
- 15.2.2 Asia Pacific Clinical Nutrition Market (USD Million) by Application (2018-2030)
- 15.2.2.1 Cancer
- 15.2.2.1.1 Asia Pacific Cancer Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.2 Metabolic Disorders
- 15.2.2.2.1 Asia Pacific Metabolic Disorders Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.3 Gastrointestinal Disorders
- 15.2.2.3.1 Asia Pacific Gastrointestinal Disorders Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.4 Neurological Disorders
- 15.2.2.4.1 Asia Pacific Neurological Disorders Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.5 Others
- 15.2.2.5.1 Asia Pacific Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.1 Cancer
- 15.2.3 Asia Pacific Clinical Nutrition Market (USD Million) by End User (2018-2030)
- 15.2.3.1 Infant And Child
- 15.2.3.1.1 Asia Pacific Infant And Child Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.2 Adults
- 15.2.3.2.1 Asia Pacific Adults Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.3 Geriatrics
- 15.2.3.3.1 Asia Pacific Geriatrics Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.1 Infant And Child
- 15.2.1 Asia Pacific Clinical Nutrition Market (USD Million) by Type (2018-2030)
- 16.1 Latin America
- 16.1.1 Latin America Clinical Nutrition Market Trends and Analysis
- 16.1.2 Latin America Clinical Nutrition Market by Country, 2018-2030
- 16.1.3 Latin America Clinical Nutrition Market Attractiveness Analysis by Country
- 16.2 Latin America Clinical Nutrition Market Size (2018-2030)
- 16.2.1 Latin America Clinical Nutrition Market (USD Million) by Type (2018-2030)
- 16.2.1.1 Infant Nutrition
- 16.2.1.1.1 Latin America Infant Nutrition Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.2 Enteral Nutrition
- 16.2.1.2.1 Latin America Enteral Nutrition Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.3 Parenteral Nutrition
- 16.2.1.3.1 Latin America Parenteral Nutrition Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.1 Infant Nutrition
- 16.2.2 Latin America Clinical Nutrition Market (USD Million) by Application (2018-2030)
- 16.2.2.1 Cancer
- 16.2.2.1.1 Latin America Cancer Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.2 Metabolic Disorders
- 16.2.2.2.1 Latin America Metabolic Disorders Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.3 Gastrointestinal Disorders
- 16.2.2.3.1 Latin America Gastrointestinal Disorders Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.4 Neurological Disorders
- 16.2.2.4.1 Latin America Neurological Disorders Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.5 Others
- 16.2.2.5.1 Latin America Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.1 Cancer
- 16.2.3 Latin America Clinical Nutrition Market (USD Million) by End User (2018-2030)
- 16.2.3.1 Infant And Child
- 16.2.3.1.1 Latin America Infant And Child Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.2 Adults
- 16.2.3.2.1 Latin America Adults Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.3 Geriatrics
- 16.2.3.3.1 Latin America Geriatrics Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.1 Infant And Child
- 16.2.1 Latin America Clinical Nutrition Market (USD Million) by Type (2018-2030)
- 17.1 Middle East and Africa
- 17.1.1 Middle East and Africa Clinical Nutrition Market Trends and Analysis
- 17.1.2 Middle East and Africa Clinical Nutrition Market by Country, 2018-2030
- 17.1.3 Middle East and Africa Clinical Nutrition Market Attractiveness Analysis by Country
- 17.2 Middle East and Africa Clinical Nutrition Market Size (2018-2030)
- 17.2.1 Middle East and Africa Clinical Nutrition Market (USD Million) by Type (2018-2030)
- 17.2.1.1 Infant Nutrition
- 17.2.1.1.1 Middle East and Africa Infant Nutrition Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.2 Enteral Nutrition
- 17.2.1.2.1 Middle East and Africa Enteral Nutrition Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.3 Parenteral Nutrition
- 17.2.1.3.1 Middle East and Africa Parenteral Nutrition Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.1 Infant Nutrition
- 17.2.2 Middle East and Africa Clinical Nutrition Market (USD Million) by Application (2018-2030)
- 17.2.2.1 Cancer
- 17.2.2.1.1 Middle East and Africa Cancer Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.2 Metabolic Disorders
- 17.2.2.2.1 Middle East and Africa Metabolic Disorders Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.3 Gastrointestinal Disorders
- 17.2.2.3.1 Middle East and Africa Gastrointestinal Disorders Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.4 Neurological Disorders
- 17.2.2.4.1 Middle East and Africa Neurological Disorders Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.5 Others
- 17.2.2.5.1 Middle East and Africa Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.1 Cancer
- 17.2.3 Middle East and Africa Clinical Nutrition Market (USD Million) by End User (2018-2030)
- 17.2.3.1 Infant And Child
- 17.2.3.1.1 Middle East and Africa Infant And Child Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.2 Adults
- 17.2.3.2.1 Middle East and Africa Adults Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.3 Geriatrics
- 17.2.3.3.1 Middle East and Africa Geriatrics Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.1 Infant And Child
- 17.2.1 Middle East and Africa Clinical Nutrition Market (USD Million) by Type (2018-2030)
- 18.1 Key Takeaways
- 18.2 Analyst Point of View
- 18.3 Assumptions
Segmentation Level Customization | |
Global level Data Customization | |
Region level Data Customization | |
Country level Data Customization | |
Company Level | |
Additional Data Analysis | |
Additional Qualitative Data | |
Additional Quantitative Data | |
Service Level Customization | Report Format Alteration |
We have various report editions of Clinical Nutrition Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Clinical Nutrition Market Analysis
Global Clinical Nutrition Market Report 2023 talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Clinical Nutrition Industry growth. Clinical Nutrition market has been segmented with the help of its Type, Application End User, and others. Clinical Nutrition market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Report scope is customizable as we have a huge database of Clinical Nutrition industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Major Type Analysed |
|
Major Application Analysed |
|
Major End User Analysed |
|
Top Manufacturers Disclosed |
|
Global, Regional and Country Analysis |
|
Key Qualitative Information Covered |
|
Type Segment Analysis of Clinical Nutrition Market
Based on present and future trends, the market size is estimated from 2018 to 2030. Moreover, study also provides quantitative and qualitative analysis of each type to understand the driving factors for the fastest growing type segment for Clinical Nutrition market.
Type of Clinical Nutrition analyzed in this report are as follows:
- Infant Nutrition
- Enteral Nutrition
- Parenteral Nutrition
Clinical Nutrition Market Share (%) by Type in 2018-2030
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Clinical Nutrition Industry. Request a Free Sample PDF!
Application Segment Analysis of Clinical Nutrition Market
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities for each application of Clinical Nutrition from 2018 to 2030. This will also help to analyze the demand for Clinical Nutrition across different end-use industries. Our research team will also help acquire additional data such as Value Chain, Patent analysis, Company Evaluation Quadrant (Matrix), and much more confidential analysis and data insights.
Some of the key Application of Clinical Nutrition are:
- Cancer
- Metabolic Disorders
- Gastrointestinal Disorders
- Neurological Disorders
- Others
Clinical Nutrition Market Share (%) by Application in 2018-2030
The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Clinical Nutrition market report 2023 Edition by contacting our team.
Clinical Nutrition End User Segment Analysis
- Infant And Child
- Adults
- Geriatrics
The North America Clinical Nutrition Market holds the major share!
Geographically, the global market is divided into North America, Europe, Asia Pacific, Latin America, and Middle-east Countries. North America region is further bifurcated into U.S., Canada, Mexico. The Europe region is further characterized into U.K., France, Germany, and Rest of Europe. Asia Pacific is further divided into China, Japan, India, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, and Rest of Latin America. Middle East & Africa region covers the UAE, South Africa, and Rest of MEA. North America holds the major share of the total market due to the presence of large leading players and well-developed telecommunication industry in the region.
Region-wise, the market is analyzed across: (In case you wish to acquire a specific region or any country data then please contact us)
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Clinical Nutrition Market Share (%) by Region (2018-2030)
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
Clinical Nutrition Industry News:
- April 30, 2022
Abbott Laboratories has released limited quantities of nutrition products that had been put on hold following a recall of some powdered infant formulas from Michigan facility.
- December 19, 2022
Abbott Laboratories plans to permaneantely stop selling of infant-formula in Chinese market due to the heavy competition in the region.
- March 13, 2021
Abbott Laboratories collaborates with Nutrition Society of India to create awareness on clinical dietary recommendations for GI (gastrointestinal) patients.
- May 27, 2020
Danone’s Nutricia grants USD 1 million for global nutrition research for COVID-19 patients
- July 16, 2020
Danone invests USD 108.14 million to strengthen Specialized Nutrition in China, further serving Chinese health needs while becoming the biggest B Corp™ company in Asia.
Top Companies Market Share in Clinical Nutrition Industry: (In no particular order of Rank)
- Abbott Nutrition
- B. Braun Melsungen
- Baxter International
- Claris Lifesciences
- Claris Otsuka Private
- Fresenius Kabi
- Groupe Danone
- Huarui Pharmaceutical
- ICU Medical
- Mead Johnson Nutrition
- Meiji
- Nestl Health Science
- Nutricia North America
- Otsuka Pharmaceutical Factory
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables..
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Clinical Nutrition Market is witnessing significant growth in the near future.
In 2022, the Infant Nutrition segment accounted for noticeable share of global Clinical Nutrition Market and is projected to experience significant growth in the near future.
The Cancer segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Abbott Nutrition, Baxter International and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Author's Detail
Nisha Deore, LinkedIn
Research Analyst at Cognitive Market Research
I am a well-organized, conscientious, and professional Research Analyst with two plus years of experience. In my current role, I conduct in-depth secondary research, data mining, competitive analysis, DRO's, PR, and Collateral writing. Whilst I enjoy working as part of a team, researching information, analyzing data, and producing results that help my organization to achieve its commercial and financial objectives.
Key Questions Answered By Clinical Nutrition Market Report 2023
Why Infant Nutrition have a significant impact on Clinical Nutrition market? |
What are the key factors affecting the Infant Nutrition and Enteral Nutrition of Clinical Nutrition Market? |
What is the CAGR/Growth Rate of Cancer during the forecast period? |
By type, which segment accounted for largest share of the global Clinical Nutrition Market? |
Which region is expected to dominate the global Clinical Nutrition Market within the forecast period? |
Frequently Asked Questions
Related Reports
- Measures to Explore Untapped Market
- Understanding Market Dynamics
- Understanding Changing Economics
- Competitors Market Share
- Global/Region/Country Level Analysis
- Identify Upcoming End Use Industries
- Global Price Trend Analysis
- Value Chain Analysis
- Customer Sentiment/Need Analysis
- Identification of Key Growth Segments
- Industry Upstream and Downstream Analysis
- Raw Material Sourcing and Cost Analysis
- Identify Key Customers Across Globe
- Concept Development and Market Testing
- Merger-Acquisition Strategy
- The research study and report are been made exclusively for an institution or person who is strategizing to build a business or strategically wants to expand certain portfolio.
- This report will help in analyzing complete market scenario across the globe who wish to expand their current business or is willing to invest in some profitable sector.
- This report will prove beneficial for person or an organization who wish to be updated regarding their business environment, consumers’ behaviour, and their requirements. The environment is constantly changing, and in such scenario, this report will help in understanding market parameters through 360-degree view.
- The report is thus ideal for KOL, CEO's, CFO's, directors, and others. It is also helpful to senior executives, business development managers, marketing managers, and consultants. Furthermore, government bodies, agencies and other kind of organizations can also leverage our report to understand market.
- Our objective for the Clinical Nutrition market is to help in making imperative business decisions, securing investments, determining new business opportunities in the market. Further, the report helps to analyze overall marketing needs of customers, and avoid business failures.
- To know the potential market size and growth rate before launching a new product line. The report in a way helps in designing R&D budget wisely by estimating maximum total profit.
- To identify the Clinical Nutrition market dynamics, industrial insights, and economic progression for critical information about the market conditions and specific business landscape.
- To assess the overall competitive landscape of a particular business sector and to provide complete analysis in regards with various external factors impacting the market growth.
- To create a strong foundation for building a strategy and foster insight into market conditions so that market players can make better business decisions. Besides, we aim to provide a complete portfolio of the major players involved the market.
- To define the scope which will further help in creating new products that will surpass the gap between current offerings and customers’ needs.
- To help in revealing significant clues concerning buying habits, regional culture, lifestyle, and population density that plays an integral role in shaping market behavior.
- To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the total market.
- Competitors Analysis: We provide data from the supplier side covering key details such as market share split among 1st tier, 2nd tier, and 3rd tier, Emerging Players, and Start-Ups. (whereas most of our competitors published data for top-tier companies)
- We provide market revenue share not only for Public listed companies but also the privately listed companies.
- Country Analysis: The Country level market split analysis is part of the report hence the data granularity is provided.
- We have been closely working with the Top 500 Fortune businesses, our clientele spanning 20+ industries. Our clientele is a mix of investors, manufacturers, end-users, distributors, etc. With our data subscription model (Athenaeum) 70% of clients have already subscribed/purchased reports for multiple years which helped us achieve unbelievable client retention statistics.
- Product + Service: In terms of the product we deliver the report access (PDF+ PPT+ EXCEL+ Cloud+ POWER BI) whereas in terms of service; we provide data support where a dedicated research analyst will be assigned and add-on benefits. (Whereas most of our competitors believe only in delivering the data/report and service and support remain questionable.)
- Credibility and Data Accuracy: We deliver accuracy close to 90-95% with the help of our in-house research team, freelancer, and industry expert network, sources present worldwide. This Data is backed up by strong What are our clients saying about our services.
Read more